Clinical Trials
2 trialsNCT03675893 2025-06-15
RESOLVE: Abemaciclib + Letrozole +/- Metformin, Zotatifin, or Gedatolisib in Endometrial or Low-Grade Serous Ovarian Cancer
Dana-Farber Cancer Institute
Phase 2 Recruiting
NCT02549989 2023-02-22
Study of LY3023414 for the Treatment of Recurrent or Persistent Endometrial Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Completed